$59.24
Value $85.1B
FCX and PRLB stock compared: price, dividend, valuation and results, from SEC filings.
$59.24
Value $85.1B
$67.55
Value $1.6B
Freeport-McMoRan (FCX) has a market value of $85.1B and Proto Labs (PRLB) $1.6B. Over the last year, with dividends, FCX moved +43.0% and PRLB +35.6%. The P/E is 24.7 for FCX and 45.9 for PRLB. Dividend yield: FCX 1.01%, PRLB none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
FCX$85.1B
PRLB$1.6B
FCX is 53 times PRLB
Revenue, 12 months
FCX$26.4B
PRLB$579M
FCX is 46 times PRLB
Net income, 12 months
FCX$3.4B
PRLB$35M
FCX is 98 times PRLB
Operating margin
FCX27.6%
PRLB7.3%
20.3 points apart
ROIC
FCX18.0%
PRLB4.5%
13.5 points apart
P/E
FCX24.7
PRLB45.9
PRLB is 1.9 times FCX
Dividend yield
FCX1.0%
PRLB0.0%
1.0 points apart
5-year return
FCX+54.0%
PRLB+14.0%
40.0 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
FCX+54.0%
PRLB+14.0%
| Period | FCXWith dividends | PRLBWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +43.0%Price +41.7% | +35.6%Price +35.6% |
| 3 years since November 13, 2023 | +83.9%+22.5% a yearPrice +77.2% | +92.6%+24.4% a yearPrice +92.6% |
| 5 years since November 12, 2021 | +54.0%+9.0% a yearPrice +43.7% | +14.0%+2.7% a yearPrice +14.0% |
| 10 years since November 15, 2016 | +371.1%+16.8% a yearPrice +323.4% | +27.6%+2.5% a yearPrice +27.6% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
FCXFreeport-McMoRanPRLBProto Labs
| Price | $59.24 | $67.55 |
|---|---|---|
| Market value | $85.1B | $1.6B |
| Enterprise value (EV) | $90.2B | $1.5B |
| P/E | 24.7 | 45.9 |
| P/E, 5-year median | – | 58.3 |
| P/B | 4.1 | 2.3 |
| EV/EBIT | 12.4 | 34.3 |
| Free cash flow yield | 2.3% | 3.0% |
| Revenue, 12 months | $26.4B | $579M |
|---|---|---|
| Net income, 12 months | $3.4B | $35M |
| Free cash flow, 12 months | $1.9B | $49M |
| Earnings per share, 12 months | $2.40 | $1.43 |
| Revenue growth, year on year | 1.8% | 6.4% |
| Revenue growth a year, past | +12.8%over 5 years | +4.2%over 5 years |
| EPS growth a year, past | – | -14.2%over 5 years |
| Gross margin | 28.0% | 45.2% |
|---|---|---|
| Operating margin | 27.6% | 7.3% |
| Net margin | 13.0% | 6.0% |
| ROIC | 18.0% | 4.5% |
| ROE | 17.5% | 5.1% |
| Cash | $4.3B | $151M |
|---|---|---|
| Total debt | $10.4B | $3.9M |
| Net debt / EBITDA | 0.5 | -2.0 |
| Interest cover | – | – |
| Dividend yield | 1.0% | – |
|---|---|---|
| Dividend per share, 12 months | $0.60 | – |
| Dividend growth a year, past | – | – |
| Buyback yield | 0.1% | 2.7% |
| Shareholder yield | 1.1% | 2.7% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Freeport-McMoRan ($85.1B) is about 53.0 times Proto Labs ($1.6B), at today's prices.
Since November 15, 2016, FCX's price moved +323.4% and PRLB's +27.6%. With dividends: FCX +371.1% (+16.8% a year), PRLB +27.6% (+2.5% a year). Past returns do not predict future ones.
The dividend yield at today's price is 1.01% for Freeport-McMoRan and none for Proto Labs. Over the last twelve months they paid $0.60 and – per share.
At today's price, the P/E is 24.7 for FCX and 45.9 for PRLB. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 13.0% for Freeport-McMoRan and 6.0% for Proto Labs, and the operating margin 27.6% and 7.3%. Revenue was $26.4B and $579M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.